Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

“…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T_regs notably decreases, indicating the restoration of immune responses. …”

Data supporting this article. by Karel Joineau (21799908)

“…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

“…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T_regs notably decreases, indicating the restoration of immune responses. …”

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

“…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T_regs notably decreases, indicating the restoration of immune responses. …”

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

“…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T_regs notably decreases, indicating the restoration of immune responses. …”

Demographic and clinical data at baseline. by Karel Joineau (21799908)

“…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”

Changes in clinical variables. by Karel Joineau (21799908)

“…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”

The mineral compositions detected by the XRD method in Fig 20. by Liang Li (46069)

Elemental compositions detected by the EDS method corresponding to Fig 25. by Liang Li (46069)

Hematological parameters. by Nida Saleem (17194610)

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Gene ontology enrichment analysis. by Zeynab Hosseinpoor (19762319)

Unraveling the Anticancer Potential of SSRIs in Prostate Cancer by Combining Computational Systems Biology and <i>In Vitro</i> Analyses by Sanaa K. Bardaweel (9636542)

“…The combination of SSRIs with cisplatin, 5-fluorouracil, and raloxifene resulted in either synergistic or additive effects. SSRIs resulted in a significant increase in the early and late apoptotic activity in PC3 cells. …”

Effect of corrections on connectivity maps. by Jan Willem Koten (17743224)

Antibacterial activity of medium derived from non-stimulated hADSCs (S) and stimulated by interferon gamma (ICM) on the growth of <i>P. aeruginosa, P. mirabilis</i> and <i>MRSA.</i... by Parisa Afzal Haghjoo (22453647)

Histograms of <i>I</i>_s and Δ<i>D.</i> by Hong Zhang (25820)

<i>upd3</i> loss-of-function mutations suppress the synthetic lethal phenotype of <i>Gpdh1</i>^{<i>A10/B18</i>}<i>; Ldh</i>^<i>16/17</i> double mutants. by Madhulika Rai (4352803)

Testing equipment and typical specimen failure modes: by Hong Zhang (25820)

Flow cytometry analysis of ADSCs markers expression. by Parisa Afzal Haghjoo (22453647)